Indications

Cipralex is licenced for the treatment of major depressive disorder (MDD), generalised anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD) and obsessive compulsive disorder (OCD)

A large collection of studies have been carried out to assess the efficacy and safety of Cipralex across its licenced indications and also in complarison to other available treatments.  To learn more, please select which disease area you wish to review:

Published: 17/04/2006   Last updated: 27/07/2010
 

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us

Lundbeck logo